Pulmonary Tuberculosis V
Pulmonary Tuberculosis I
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Therapeutic Drug Monitoring: Affecting Factors
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis IV
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 1, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
R M Anthony1, M Cynamon2, S Hoffner3
1Tuberculosis Reference Laboratory, Center for Infectious Disease Research, Diagnostics and Perinatal Screening (IDS), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands r.anthony@planet.nl.
No abstract available in PubMed .